RESOURCES | PRESENTATIONS, PUBLICATIONS, AND POSTERS | Integrated Comprehensive Analysis of Immune Cell subsets and Assessment of Keytruda Response in Head and Neck Squamous Cell Carcinoma, Urothelial Cell Carcinoma, and Renal Cell Carcinoma Ex-vivo
     

    Integrated Comprehensive Analysis of Immune Cell subsets and Assessment of Keytruda Response in Head and Neck Squamous Cell Carcinoma, Urothelial Cell Carcinoma, and Renal Cell Carcinoma Ex-vivo

    Apr 18, 2018

    Melba Marie Page Ph.D., Melanie Mediavilla-Varela Ph.D., Soner Altiok, M.D., Ph.D. Jenny Kreahling, Ph.D. Nilogen Oncosystems, H. Lee Moffitt Cancer Center.  American Association for Cancer Research (AACR) 2018 Annual Meeting.  04/14/2018 to 04/18/18. Chicago, IL, USA

    DOWNLOAD poster

    OTHER PUBLICATIONS

    Employing ex vivo 3D-Screen technology for the development of rational combinations of immuno-oncology drugs in tumor organoids of fresh patient tissue

    Employing ex vivo 3D-Screen technology for the development of rational combinations of immuno-oncology drugs in tumor organoids of fresh patient tissue

    Jared Ehrhart, Ph.D., Mibel Pabón, Ph.D., Tina Pastoor...

    Jun 22, 2020

    Optimization of checkpoint inhibitor-TKI combinations in renal cell carcinoma using an ex vivo 3D tumor organoid model of fresh patient tissue with intact TME

    Optimization of checkpoint inhibitor-TKI combinations in renal cell carcinoma using an ex vivo 3D tumor organoid model of fresh patient tissue with intact TME

    Jared C. Ehrhart, Ph.D., Mibel Pabón, Ph.D., Tina Past...

    Jun 22, 2020

    Leveraging Artificial Intelligence to Advance Immuno-oncology Drug Development Using Functional Ex Vivo 3D-tumor Organoid Platforms of Fresh Patient Samples

    Leveraging Artificial Intelligence to Advance Immuno-oncology Drug Development Using Functional Ex Vivo 3D-tumor Organoid Platforms of Fresh Patient Samples

    Vijayendra Agrawal Ph.D. , Mibel Pabon, Ph.D. , Tina Pa...

    Nov 13, 2019

    SHOW MORE